188 related articles for article (PubMed ID: 28744323)
1. In-depth Characterization of a TCR-specific Tracer for Sensitive Detection of Tumor-directed Transgenic T Cells by Immuno-PET.
Yusufi N; Mall S; Bianchi HO; Steiger K; Reder S; Klar R; Audehm S; Mustafa M; Nekolla S; Peschel C; Schwaiger M; Krackhardt AM; D'Alessandria C
Theranostics; 2017; 7(9):2402-2416. PubMed ID: 28744323
[TBL] [Abstract][Full Text] [Related]
2. Immuno-PET Imaging of Engineered Human T Cells in Tumors.
Mall S; Yusufi N; Wagner R; Klar R; Bianchi H; Steiger K; Straub M; Audehm S; Laitinen I; Aichler M; Peschel C; Ziegler S; Mustafa M; Schwaiger M; D'Alessandria C; Krackhardt AM
Cancer Res; 2016 Jul; 76(14):4113-23. PubMed ID: 27354381
[TBL] [Abstract][Full Text] [Related]
3. T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target.
Mayer KE; Mall S; Yusufi N; Gosmann D; Steiger K; Russelli L; Bianchi HO; Audehm S; Wagner R; Bräunlein E; Stelzl A; Bassermann F; Weichert W; Weber W; Schwaiger M; D'Alessandria C; Krackhardt AM
Theranostics; 2018; 8(21):6070-6087. PubMed ID: 30613283
[TBL] [Abstract][Full Text] [Related]
4. The PET-Tracer
Griessinger CM; Olafsen T; Mascioni A; Jiang ZK; Zamilpa C; Jia F; Torgov M; Romero JM; Marchioni F; Satpayev D; Lee C; Zhang G; Nayak TK; Pincha M; Amann M; Mohan PLB; Richard M; Nicolini VG; Sam J; Claus C; Ferrara C; Brünker P; Bacac M; Umana P; Rüttinger D; Wilson IA; Gudas J; Klein C; Tessier JJL
Cancer Res; 2020 Jul; 80(13):2903-2913. PubMed ID: 32409308
[TBL] [Abstract][Full Text] [Related]
5. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Evaluation of
Maresca KP; Chen J; Mathur D; Giddabasappa A; Root A; Narula J; King L; Schaer D; Golas J; Kobylarz K; Rosfjord E; Keliher E; Chen L; Ram S; Pickering EH; Hardwick JS; Rejto PA; Hussein A; Ilovich O; Staton K; Wilson I; McCarthy TJ
Mol Imaging Biol; 2021 Dec; 23(6):941-951. PubMed ID: 34143379
[TBL] [Abstract][Full Text] [Related]
7. Advances in PET Detection of the Antitumor T Cell Response.
McCracken MN; Tavaré R; Witte ON; Wu AM
Adv Immunol; 2016; 131():187-231. PubMed ID: 27235684
[TBL] [Abstract][Full Text] [Related]
8. Spatio-temporal biodistribution of
Sta Maria NS; Khawli LA; Pachipulusu V; Lin SW; Zheng L; Cohrs D; Liu X; Hu P; Epstein AL; Jacobs RE
Sci Rep; 2021 Jul; 11(1):15077. PubMed ID: 34302002
[TBL] [Abstract][Full Text] [Related]
9. Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses.
Koya RC; Mok S; Comin-Anduix B; Chodon T; Radu CG; Nishimura MI; Witte ON; Ribas A
Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14286-91. PubMed ID: 20624956
[TBL] [Abstract][Full Text] [Related]
10. Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma.
Sun L; Guo H; Jiang R; Lu L; Liu T; He X
Tumour Biol; 2016 Jan; 37(1):799-806. PubMed ID: 26250457
[TBL] [Abstract][Full Text] [Related]
11. 64Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET.
Griessinger CM; Maurer A; Kesenheimer C; Kehlbach R; Reischl G; Ehrlichmann W; Bukala D; Harant M; Cay F; Brück J; Nordin R; Kohlhofer U; Rammensee HG; Quintanilla-Martinez L; Schaller M; Röcken M; Pichler BJ; Kneilling M
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1161-6. PubMed ID: 25587131
[TBL] [Abstract][Full Text] [Related]
12. Genetically modified human CD4(+) T cells can be evaluated in vivo without lethal graft-versus-host disease.
Ali R; Babad J; Follenzi A; Gebe JA; Brehm MA; Nepom GT; Shultz LD; Greiner DL; DiLorenzo TP
Immunology; 2016 Aug; 148(4):339-51. PubMed ID: 27124592
[TBL] [Abstract][Full Text] [Related]
13. PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.
Hoeben BA; Kaanders JH; Franssen GM; Troost EG; Rijken PF; Oosterwijk E; van Dongen GA; Oyen WJ; Boerman OC; Bussink J
J Nucl Med; 2010 Jul; 51(7):1076-83. PubMed ID: 20554724
[TBL] [Abstract][Full Text] [Related]
14. Functional comparison of engineered T cells carrying a native TCR versus TCR-like antibody-based chimeric antigen receptors indicates affinity/avidity thresholds.
Oren R; Hod-Marco M; Haus-Cohen M; Thomas S; Blat D; Duvshani N; Denkberg G; Elbaz Y; Benchetrit F; Eshhar Z; Stauss H; Reiter Y
J Immunol; 2014 Dec; 193(11):5733-43. PubMed ID: 25362181
[TBL] [Abstract][Full Text] [Related]
15. An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.
Tavaré R; Escuin-Ordinas H; Mok S; McCracken MN; Zettlitz KA; Salazar FB; Witte ON; Ribas A; Wu AM
Cancer Res; 2016 Jan; 76(1):73-82. PubMed ID: 26573799
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging.
McCracken MN; Vatakis DN; Dixit D; McLaughlin J; Zack JA; Witte ON
J Clin Invest; 2015 May; 125(5):1815-26. PubMed ID: 25822024
[TBL] [Abstract][Full Text] [Related]
17. Transgenic CD8αβ co-receptor rescues endogenous TCR function in TCR-transgenic virus-specific T cells.
Bajwa G; Lanz I; Cardenas M; Brenner MK; Arber C
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33148692
[TBL] [Abstract][Full Text] [Related]
18. Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies.
Tavaré R; McCracken MN; Zettlitz KA; Salazar FB; Olafsen T; Witte ON; Wu AM
J Nucl Med; 2015 Aug; 56(8):1258-64. PubMed ID: 25952734
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD3 epsilon F(ab')2 fragments inhibit T cell expansion in vivo during graft-versus-host disease or the primary immune response to nominal antigen.
Blazar BR; Jenkins MK; Taylor PA; White J; Panoskaltsis-Mortari A; Korngold R; Vallera DA
J Immunol; 1997 Dec; 159(12):5821-33. PubMed ID: 9550378
[TBL] [Abstract][Full Text] [Related]
20. ImmunoPET Imaging of CD146 Expression in Malignant Brain Tumors.
Hernandez R; Sun H; England CG; Valdovinos HF; Barnhart TE; Yang Y; Cai W
Mol Pharm; 2016 Jul; 13(7):2563-70. PubMed ID: 27280694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
